Genetic characterization of human immunodeficiency virus type 1 Tat before and after highly active antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 20, Issue 10, 2004, Pages 1108-1112

  Lorenzo, Eric ^a   Kumar, Rakesh ^a   Hill, Martin D ^a   Costa, Sonia ^a   Chaudhary, Suman ^a   Tirado, Grissell ^a   Yamamura, Yashuhiro ^a   Kumar, Anil ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; TENOFOVIR; TRANSACTIVATOR PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CLONE; EXON; GENE AMPLIFICATION; GENE MUTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; LYMPHOCYTE COUNT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AMINO ACID SEQUENCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; EVOLUTION, MOLECULAR; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VIRAL LOAD;

EID: 6344269431     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.1108     Document Type: Article

References (16)

1. Pomerantz RJ: Reservoirs, sanctuaries, and residual disease: The hiding spots of HIV-1. HIV Clin Trials 2003;4:137-143.
2. Richman DD: HIV chemotherapy. Nature 2001;410:995-1001.
3. Kieffer TL, Finucane MM, Nettles RE, et al.: Genotypic analysis of HIV-1 drug resistance at the limit of detection: Virus production without evolution in treated adults with undetectable HIV loads. J Infect Dis 2004;189:1452-1465.
4. Tirado G, Jove G, Kumar R, et al: Differential HIV-1 evolution in blood and genital tract of HIV-infected females: Evidence for the involvement of drug resistant and no drug resistance-associated mutations. Virology 2004;324:577-586.
5. Feinberg MB, Baltimore D, and Frankel AD: The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc Natl Acad Sci USA 1991;88:4045-4049.
6. van Baalen CA, Pontesilli O, Huisman RC, et al.: Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J Gen Virol 1997;78:1913-1918.
7. Zagury JF, Sill A, Blattner W, et al.: Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: A rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol 1998;1:282-292.
8. Allen TM, O'Connor DH, Jing P, et al: Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000;407:386-390.
9. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111-120.
10. Izopet J, Cazabat M, Pasquier C, et al: Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression. Virology 2002;302: 393-404.
11. Jeang KT, Xiao H, and Rich EA: Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 1999;274: 28837-28840.
12. Korber B: HIV Signature and sequence variation analysis. In: Computational nalysis of HIV Molecular Sequences. (Rodrigo AG, Learn GH, eds.). Kluwer Academic Publishers, Dordrecht, Netherlands, 2000, pp. 55-72.
13. Yang W, Bielawski JP, and Yang Z: Widespread adaptive evolution in the human immunodeficiency virus type 1 genome. J Mol Evol 2003;57:212-221.
14. Churcher MJ, Lamont C, Hamy F, et al.: High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol 1993;230:90-110.
15. Luo Y and Peterlin BM: Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR. J Virol 1993;67:3441-3445.
16. Dingwall C, Ernberg I, Gait MJ, et al.: Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 1989; 86:6925-6929.